DE60035497D1 - Verfharen zur konservierung von viren und mycoplasma - Google Patents

Verfharen zur konservierung von viren und mycoplasma

Info

Publication number
DE60035497D1
DE60035497D1 DE60035497T DE60035497T DE60035497D1 DE 60035497 D1 DE60035497 D1 DE 60035497D1 DE 60035497 T DE60035497 T DE 60035497T DE 60035497 T DE60035497 T DE 60035497T DE 60035497 D1 DE60035497 D1 DE 60035497D1
Authority
DE
Germany
Prior art keywords
mycoplasma
procedure
viruses
preserving
preserving viruses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60035497T
Other languages
English (en)
Other versions
DE60035497T2 (de
Inventor
Eric Edward Worrall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anhydro Ltd
Original Assignee
Anhydro Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9909999.6A external-priority patent/GB9909999D0/en
Priority claimed from GBGB9926698.3A external-priority patent/GB9926698D0/en
Application filed by Anhydro Ltd filed Critical Anhydro Ltd
Publication of DE60035497D1 publication Critical patent/DE60035497D1/de
Application granted granted Critical
Publication of DE60035497T2 publication Critical patent/DE60035497T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04Preserving or maintaining viable microorganisms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18411Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18451Methods of production or purification of viral material
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/87Mycoplasma
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/948Microorganisms using viruses or cell lines

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DE60035497T 1999-05-04 2000-05-03 Verfharen zur konservierung von viren und mycoplasma Expired - Fee Related DE60035497T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9909999.6A GB9909999D0 (en) 1999-05-04 1999-05-04 Protection of sensitive viruses and bacteria in vaccines
GB9909999 1999-05-04
GBGB9926698.3A GB9926698D0 (en) 1999-11-12 1999-11-12 Method for the preserving of viruses, bacteria and biomolecules
GB9926698 1999-11-12
PCT/GB2000/001524 WO2000066710A2 (en) 1999-05-04 2000-05-03 Method for the preservation of viruses and mycoplasma

Publications (2)

Publication Number Publication Date
DE60035497D1 true DE60035497D1 (de) 2007-08-23
DE60035497T2 DE60035497T2 (de) 2007-10-31

Family

ID=26315490

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60035497T Expired - Fee Related DE60035497T2 (de) 1999-05-04 2000-05-03 Verfharen zur konservierung von viren und mycoplasma

Country Status (18)

Country Link
US (1) US6664099B1 (de)
EP (1) EP1175486B1 (de)
JP (1) JP2002542815A (de)
KR (1) KR100616195B1 (de)
CN (1) CN1433465A (de)
AP (1) AP1521A (de)
AT (1) ATE366797T1 (de)
AU (1) AU776982B2 (de)
BR (1) BR0010249A (de)
CA (1) CA2365277A1 (de)
DE (1) DE60035497T2 (de)
DK (1) DK1175486T3 (de)
EA (1) EA004131B1 (de)
ES (1) ES2290028T3 (de)
MX (1) MXPA01011145A (de)
OA (1) OA11936A (de)
TR (1) TR200103149T2 (de)
WO (1) WO2000066710A2 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0301436D0 (sv) * 2003-05-16 2003-05-16 Joakim Westberg New proteins
RU2418633C2 (ru) 2004-04-08 2011-05-20 Байоматрика, Инк. Объединение процессов хранения образцов и управление образцами в медико-биологических науках
JP5214464B2 (ja) 2005-12-28 2013-06-19 アドバンスド バイオニュートリション コーポレーション 多糖類、糖類およびポリオール類の乾燥マトリックスを含む、ガラス形態の、プロバイオティクス細菌用送達媒体およびその製造方法
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
WO2008076975A1 (en) 2006-12-18 2008-06-26 Advanced Bionutrition Corporation A dry food product containing live probiotic
HUE031617T2 (en) 2007-04-06 2017-07-28 Takeda Vaccines Inc Methods and preparations for live attenuated viruses
KR101540920B1 (ko) * 2007-07-26 2015-08-03 사노피 파스퇴르 리미티드 항원-애주번트 조성물 및 방법
DE102007036695A1 (de) * 2007-08-03 2009-02-05 Ab Skf Getriebelageranordnung mit wenigstens einem zweireihigen Schrägkugellager
CA2986751A1 (en) 2009-03-27 2010-09-30 Intervet International B.V. Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
JP5841527B2 (ja) 2009-05-26 2016-01-13 アドバンスド バイオニュートリション コーポレーション 生物学的に活性な微生物および/または生物活性材料を含む安定な乾燥粉末組成物およびその製造方法
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
CN102725393B (zh) 2010-01-28 2015-12-02 先进生物营养公司 包含生物活性材料的干燥玻璃质组合物
EP2598661B1 (de) 2010-07-26 2017-09-27 Biomatrica, INC. Zusammensetzungen zur stabilisierung von dna, rna und proteinen in speichel- und anderen biologischen proben während des transports und der lagerung bei umgebungstemperaturen
EP2598660B1 (de) 2010-07-26 2017-03-15 Biomatrica, INC. Zusammensetzungen zur stabilisierung von dna, rna und proteinen in blut- und anderen biologischen proben während des transports und der lagerung bei umgebungstemperaturen
SG187250A1 (en) 2010-08-13 2013-03-28 Advanced Bionutrition Corp Dry storage stabilizing composition for biological materials
EA201301173A1 (ru) 2011-04-15 2015-08-31 Дженелюкс Корпорейшн Клональные штаммы аттенуированных вакцинирующих вирусов и способы их использования
US20140140959A1 (en) 2012-10-05 2014-05-22 Aladar A. Szalay Energy Absorbing-Based Diagnostic and Therapeutic Methods Employing Nucleic Acid Molecules Encoding Chromophore-Producing Enzymes
US9725703B2 (en) 2012-12-20 2017-08-08 Biomatrica, Inc. Formulations and methods for stabilizing PCR reagents
WO2015103438A2 (en) 2014-01-02 2015-07-09 Genelux Corporation Oncolytic virus adjunct therapy with agents that increase virus infectivity
WO2015191632A1 (en) 2014-06-10 2015-12-17 Biomatrica, Inc. Stabilization of thrombocytes at ambient temperatures
DK3328215T3 (da) 2015-07-29 2021-09-13 Advanced Bionutrition Corp Stabilt tørre probiotiske sammensætninger til særlige kostanvendelser
CN113588501A (zh) 2015-12-08 2021-11-02 生物马特里卡公司 降低红细胞沉降速率
CN105462840A (zh) * 2015-12-10 2016-04-06 浙江卫信生物药业有限公司 一种口腔支原体的活体冻干体的制备方法
US20240033347A1 (en) 2022-07-08 2024-02-01 Viromissile, Inc. Oncolytic vaccinia viruses and recombinant viruses and methods of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8801338D0 (en) * 1988-01-21 1988-02-17 Quadrant Bioresources Ltd Preservation of viruses
GB9125695D0 (en) * 1991-12-03 1992-01-29 Mastavac Limited Medical preparations
BR9609188A (pt) * 1995-06-07 1999-05-11 Quadrant Holdings Cambridge Métodos para incorporar substâncias de modo estável dentro de matrizes de vidro espumado secas e composições obtidas desse modo
US5766520A (en) * 1996-07-15 1998-06-16 Universal Preservation Technologies, Inc. Preservation by foam formation

Also Published As

Publication number Publication date
US6664099B1 (en) 2003-12-16
CA2365277A1 (en) 2000-11-09
KR100616195B1 (ko) 2006-08-25
OA11936A (en) 2006-04-12
EA200101167A1 (ru) 2002-06-27
AU4584400A (en) 2000-11-17
ES2290028T3 (es) 2008-02-16
EA004131B1 (ru) 2003-12-25
DK1175486T3 (da) 2007-10-29
MXPA01011145A (es) 2003-07-14
AP2001002335A0 (en) 2001-12-31
WO2000066710A2 (en) 2000-11-09
ATE366797T1 (de) 2007-08-15
EP1175486A2 (de) 2002-01-30
EP1175486B1 (de) 2007-07-11
AP1521A (en) 2005-12-22
WO2000066710A3 (en) 2001-02-08
JP2002542815A (ja) 2002-12-17
AU776982B2 (en) 2004-09-30
BR0010249A (pt) 2002-02-13
TR200103149T2 (tr) 2002-01-21
CN1433465A (zh) 2003-07-30
KR20020012201A (ko) 2002-02-15
DE60035497T2 (de) 2007-10-31

Similar Documents

Publication Publication Date Title
DE60035497D1 (de) Verfharen zur konservierung von viren und mycoplasma
DE60029313D1 (de) Anordnung zur entnahme von blutplättchen und anderen blutkomponenten
DE60037903D1 (de) Chirurgischer gefässclip und applikator
DE60033051D1 (de) Methode und einrichtung zur kontinuierlichen herstellung von diarylcarbonaten
DE69924750D1 (de) Gerät zur thermischen behandlung von gewebe
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
DE69943396D1 (de) Insufflationsanordnung, fixierung und verfahren
DE60143095D1 (de) Trokar und trokarsystem
DE69722388D1 (de) Nichtpolymere epoxyverbindungen zur vernetzung von biologischem gewebe und daraus hergestellte bioprothesen
DE60202267D1 (de) Occiputplatte und system zur stabilisierung der wirbelsäule
DE69942708D1 (de) Virus enthaltende Zusammensetzungen und Methoden zur Konzentration von Viruspräparaten
DE60020613D1 (de) (S,S)-Reboxetin zur Behandlung von Fibromyalgie und anderen somatoformen Störungen
ATE363904T1 (de) Benzimidazol-2-carbamat zur behandlung viraler infektionen und von krebs
DE19983141T1 (de) Vernetzbare Zusammensetzung und daraus erhältlicher vernetzter Gegenstand
NO20001870D0 (no) Ny fremgangsmõte for behandling
DE69904731T2 (de) Feinzerkleinerer und feinzerkleinerungsverfahren
DE60012138D1 (de) Gerät zur behandlung von fibrillation
DE60033043D1 (de) Modifizierte pflanzenviren und deren verwendungsmethoden
DE69925820D1 (de) Zubereitungen zur stabilisierung von peg-interferon alpha konjugaten
DE69936251D1 (de) Mittel zur vorbeugung und linderung der periodontose
DE69900168D1 (de) Zusammensetzung zur Behandlung von Papier und damit behandeltes Papier
DE60027429D1 (de) Dihydrobenzodiazepinen und deren verwendung zur behandlung von dyslipidämien
DE69721756T2 (de) Paroxetine zur behandlung von depression
ATE260042T1 (de) Früchte und gemüse behandlungsverfahren
DE60224650D1 (de) Vorrichtung zur behandlung von vorhof-fibrillation

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee